Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2009
08/27/2009US20090215765 Neuroprotective compounds for treating optic neuropathies
08/27/2009US20090215759 Modulators for amyloid beta
08/27/2009US20090215712 Pyrazole derivatives
08/27/2009DE102008010221A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma
08/27/2009CA2716515A1 Amine and ether compounds which modulate the cb2 receptor
08/27/2009CA2716320A1 Selective androgen receptor modulators
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
08/27/2009CA2714215A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
08/27/2009CA2713716A1 Modulators for amyloid beta
08/27/2009CA2713412A1 Amide derivative and pharmaceutical composition containing the same
08/27/2009CA2713187A1 Oxazolidinone derivatives
08/27/2009CA2712228A1 4,5-dihydro-oxazol-2-yl amine derivatives
08/26/2009EP2093220A2 Inhibitors of fatty acid amide hydrolase
08/26/2009EP2091950A1 Oxadiazole derivatives as s1p1 receptor agonists
08/26/2009EP2091949A1 Indole derivatives as s1p1 receptor agonists
08/26/2009EP2091948A1 Novel inhibitors of glutaminyl cyclase
08/26/2009EP2091945A1 Novel inhibitors of glutaminyl cyclase
08/26/2009EP2091943A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
08/26/2009EP2091941A2 Mapk/erk kinase inhibitors
08/26/2009EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
08/26/2009EP2091931A2 A process for the preparation of secotaxanes
08/26/2009EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
08/26/2009EP2091928A2 3-(2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
08/26/2009EP2091926A1 Substituted pyrazole and triazole compounds as ksp inhibitors
08/26/2009EP2091916A2 L-phenylalanine derivatives and their use as integrin antagonists
08/26/2009EP1987026B1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
08/26/2009EP1773817B1 Substituted aryl-amine derivatives and methods of use
08/26/2009EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
08/26/2009EP1173441B1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
08/26/2009CN101516876A Compounds having a potentiating effect on the activity of ethionamide and uses thereof
08/26/2009CN101516875A CGRP receptor antagonists
08/26/2009CN101516868A Novel pyridazine derivatives
08/26/2009CN101516860A Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors
08/26/2009CN101516856A Heterocyclic bridged biphenyls and their use in oleds
08/26/2009CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
08/26/2009CN101513402A Antiviral agent
08/26/2009CN100532380C Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
08/25/2009US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia
08/25/2009US7579478 Process for the purification of substituted benzoxazole compounds
08/25/2009US7579473 c-Met modulators and methods of use
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/25/2009US7579465 For treatment of picornavirus infections in mammals
08/25/2009US7579366 Epothilone derivatives and their synthesis and use
08/25/2009US7579355 Inhibitors of Akt activity
08/25/2009US7579350 Scaffolds for α-helix mimicry
08/25/2009US7579349 anticarcinogenic agent 5-Chloro-2-{2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; chemical synthesis; use in modulating insulin-like growth factor 1 receptor activity
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009US7579346 Carboxamides
08/25/2009US7579340 Cardiovascular homeostasis through combination of direct neuronal control and systemic neurohormonal activation; inflammatory bowel disease
08/25/2009US7579334 Compounds with anti-inflammatory activity
08/25/2009US7579313 Transglutaminase inhibitors and methods of use thereof
08/25/2009CA2538072C Amide-type carboxamide derivatives
08/25/2009CA2505086C Ophthalmic compositions for treating ocular hypertension
08/25/2009CA2455097C Enzyme inhibition immunoassay based on impdh inhibition by mpa
08/25/2009CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds
08/20/2009WO2009103007A2 Steroid hormone receptor modulator compounds and methods
08/20/2009WO2009101079A1 Pyrimidylmethyl sulfonamide compounds
08/20/2009WO2009101078A1 Pyrimidylmethyl sulfonamide compounds
08/20/2009WO2009101022A1 Heterocyclic antiviral compounds
08/20/2009WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/20/2009WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009WO2009081105A3 Quinoxaline and quinoline derivatives as kinase inhibitors
08/20/2009WO2009068214A3 Heteroaryl-substituted piperidines
08/20/2009WO2009043889A3 Oxadiazole derivatives
08/20/2009US20090209596 Oxazole Hydroxamic Acid Derivatives and Use Thereof
08/20/2009US20090209593 Novel antibacterial agents
08/20/2009US20090209590 Histone Deacetylase and Tubulin Deacetylase Inhibitors
08/20/2009US20090209578 Chemical compounds
08/20/2009US20090209542 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
08/20/2009US20090209540 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same
08/20/2009US20090209539 Pyrimidine derivatives as alk-5 Inhibitors
08/20/2009US20090209538 Therapeutic substituted lactams
08/20/2009US20090209536 Aminoquinazoline cannabinoid receptor modulators for treatment of disease
08/20/2009US20090209533 Aldh-2 inhibitors in the treatment of addiction
08/20/2009US20090209532 Pharmaceutical compounds
08/20/2009US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/20/2009US20090209529 4,5-dihydro-oxazol-2-yl amine derivatives
08/20/2009US20090209528 Substituted tetrahydroisoquinoline compound, their preparation and use in medicaments
08/20/2009US20090209524 Novel Compounds
08/20/2009US20090209522 Heterocyclic Non-Peptide GNRH Antagonists
08/20/2009US20090209511 Benzofuran Derivatives
08/20/2009US20090209510 Novel Method of Treating Hyperlipidemia
08/20/2009US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
08/20/2009CA2714656A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009CA2714254A1 Heterocyclic antiviral compounds
08/20/2009CA2714087A1 Inhibitors of checkpoint kinases
08/20/2009CA2713404A1 Pyrimidylmethyl sulfonamide compounds
08/20/2009CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/19/2009EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives
08/19/2009EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
08/19/2009EP2089386A2 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
08/19/2009EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists
08/19/2009EP1846379B1 Antidiabetic bicyclic compounds
08/19/2009EP1838304B1 Heterocyclic aspartyl protease inhibitors
08/19/2009EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
08/19/2009EP0774122B1 Merocyanine dye protein stains
08/19/2009CN101511827A Pyridin-4-yl derivatives as immunomodulating agents
08/19/2009CN101511815A New pyridine analogues
08/19/2009CN101511813A Heterocyclic FXR binding compounds
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 647